Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Apex Medical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - APEX Medical Corp (4106-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 May 2016 Thomson Reuters Stock Report 11 $25.00

Apex Medical Corporation (4106) - Financial Analysis Review

Apex Medical Corporation (4106) - Financial Analysis Review Summary Apex Medical Corporation (Apex Medical) is a medica...

18 May 2016 GlobalData 23 $125.00

Apex Medical Corp. (4106 TT):Brand Business Bearing Fruit with Stable Profit Growth

Apex is persistent in developing its own brand in recent years. Despite its business recession in 2015, we expect the growth ...

12 May 2016 MasterLink Securities Corporation 5 $46.00

雃博 (4106):致力成為醫材品牌廠,公司獲利穩定

雃博營收與獲利穩定成長,維持買進評等:雃博近年堅持品牌之路,公司揮別2015年的衰退低潮,在歐洲氣墊床與泛亞太地區呼吸治療器市場的成長下,元富預估2016年營收YOY+8%,EPS 2.56元,營運爆發尚待時間發酵,然公司營收與獲利穩定成長,維持買進...

09 May 2016 MasterLink Securities Corporation 4 $23.00

Wright Investors Service Comprehensive Report for Apex Medical Corp.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

02 May 2016 Wright Reports 56 $75.00

Is Apex Medical Corporation a Good Long-Term Investment?

19 Apr 2016 Sadif Analytics Prime 12 $25.00

Apex Medical Corporation (4106) - Financial Analysis Review

Apex Medical Corporation (4106) - Financial Analysis Review Summary Apex Medical Corporation (Apex Medical) is a medica...

18 Mar 2016 GlobalData 23 $125.00

Apex Medical Corp (4106 TT); Walking out of the Trough

We believe that Apex’s 1Q16 operation would beat that in 4Q15. As Apex is aggressive with market expansion in 2016, we foreca...

29 Feb 2016 MasterLink Securities Corporation 5 $46.00

雃博 (4106):堅定品牌之路 揮別營運低潮

雃博營運回升,調升至買進評等:元富認為雃博1Q16營運表現將較4Q15佳,而2016年在積極切入各地區市場下,元富預估2016年營收YOY+11%,EPS 2.60元,已揮別流失ODM訂單的營運谷底,目前本益比15X,低於過去的16~22X區間,考量...

23 Feb 2016 MasterLink Securities Corporation 4 $23.00